Date Filed | Type | Description |
04/28/2021 |
GN
| InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa |
04/27/2021 |
GN
| InMed Pharmaceuticals Announces Voluntary Delisting from TSX |
04/26/2021 |
GN
| InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™ |
03/03/2021 |
GN
| InMed to Present at Virtual Conferences in March 2021 |
06/12/2018 |
GN
| InMed Pharmaceuticals announces increase in Bought Deal offering to $13 million |
06/12/2018 |
GN
| InMed Pharmaceuticals Announces $10 Million Bought Deal |
02/10/2014 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
10/10/2013 |
SC 13G/A
| WELLS FARGO & COMPANY reports a |
09/18/2013 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Intermec, Inc. |
09/17/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/17/2013 |
4
| HINCKLEY GREGORY K (Director) has filed a Form 4 on Intermec, Inc.
Txns:
| Disposed/sold 28,221 shares
@ $10, valued at
$282.2k
Disposed/sold 24,462 options to buy
@ $0 Disposed/sold options to buy
@ $0 |
|
09/17/2013 |
4
| BARNES KEITH (Director) has filed a Form 4 on Intermec, Inc.
Txns:
| Disposed/sold 34,136 shares
@ $10, valued at
$341.4k
|
|
09/17/2013 |
4
| SAMPLE STEVEN B (Director) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| DRIESSNACK ROBERT (SVP CFO) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| Morikubo Yukio (SVP General Counsel) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| Thompson Earl (SVP Mobile Solutions Business) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| LAUER ALLEN J (Interim CEO) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| YOST LARRY D (Director) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| KENNARD LYDIA H (Director) has filed a Form 4 on Intermec, Inc.
Txns:
| Disposed/sold 24,264 shares
@ $10, valued at
$242.6k
Disposed/sold 25,000 options to buy
@ $7.72, valued at
$193k
Disposed/sold 24,462 options to buy
@ $0 |
|
09/17/2013 |
4
| REYNOLDS STEPHEN P (Director) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| FAERBER DENNIS (SVP Global Operations) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| McDonnell James (SVP Global Sales and Marketing) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
4
| DRAUT ERIC JOHN (Director) has filed a Form 4 on Intermec, Inc. |
09/17/2013 |
8-K
| Resignation/termination of a director |
09/13/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
09/11/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/08/2013 |
8-K
| Quarterly results |
08/08/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
08/08/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
06/24/2013 |
8-K
| Other Events |
06/10/2013 |
8-K
| Other Events |
05/29/2013 |
4
| Thompson Earl (SVP Mobile Solutions Business) has filed a Form 4 on Intermec, Inc.
Txns:
| Paid exercise price by delivering 1,630 shares
@ $9.88, valued at
$16.1k
Paid exercise price by delivering 4,700 shares
@ $9.88, valued at
$46.4k
Exercised 6,160 restricted stock units
@ $0 Exercised 17,184 restricted stock units
@ $0 |
|
05/29/2013 |
4
| McDonnell James (SVP Global Sales and Marketing) has filed a Form 4 on Intermec, Inc.
Txns:
| Paid exercise price by delivering 2,260 shares
@ $9.88, valued at
$22.3k
Paid exercise price by delivering 1,949 shares
@ $9.88, valued at
$19.3k
Exercised 6,160 restricted stock units
@ $0 Exercised 5,184 restricted stock units
@ $0 |
|
05/29/2013 |
4
| FAERBER DENNIS (SVP Global Operations) has filed a Form 4 on Intermec, Inc.
Txns:
| Paid exercise price by delivering 1,915 shares
@ $9.88, valued at
$18.9k
Paid exercise price by delivering 5,496 shares
@ $9.88, valued at
$54.3k
Exercised 6,160 restricted stock units
@ $0 Exercised 17,184 restricted stock units
@ $0 |
|
|